ClinicalTrials.Veeva

Menu

Incidence of Pancreatic Fistula After Radical Gastrectomy

Fudan University logo

Fudan University

Status

Unknown

Conditions

Pancreatic Fistula
Complication
Gastric Cancer

Treatments

Diagnostic Test: Amylase Test

Study type

Observational

Funder types

Other

Identifiers

NCT03391687
ZSGC-003

Details and patient eligibility

About

This study is designed to investigate the incidence of pancreatic fistula after radical gastrectomy in gastric cancer patients.

Full description

Pancreatic fistula, which can lead to fatal end, is one of the most serious complications after radical gastrectomy. It is usually treated as a key factor to evaluate the quality of gastrectomy. The incidence of pancreatic fistula is far different between different areas, knowing the prevalence of pancreatic fistula and risk factors can help us to prevent pancreatic fistula and improve the short time outcome of gastric cancer surgery treatment. So, we designed this perspective, multi-center study to investigate the incidence of pancreatic fistula and its outcome in China.

Enrollment

2,100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pathological confirmed stomach adenocarcinoma
  • preoperative curatively resectable tumor

Exclusion criteria

  • pancreas resection
  • emergent surgery due to gastric cancer acute complications
  • cancer of gastric remnant

Trial design

2,100 participants in 1 patient group

Amylase Test
Description:
gastric cancer patients receiving radical gastrectomy
Treatment:
Diagnostic Test: Amylase Test

Trial contacts and locations

20

Loading...

Central trial contact

Zhaoqing Tang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems